January 27, 2010 -- Putnam Associates, a Boston-based strategy consulting firm serving the biotechnology and pharmaceutical industries globally, is pleased to announce that Eric C. Auger, Partner, will speak today at the 2010 Pricing for New Bio-Pharmaceutical Products Conference, held on January 27-28, 2010, at The Carlton on Madison Avenue, New York. The goal of the conference is to explain the process of establishing and managing bio-pharmaceutical product pricing.
Mr. Auger’s forum, “Managed Care Contracting for New Product Launches,” taking place at 2:45 p.m., will address the following issues:
? Who should you contract with and why
? Payer controls and evaluating their impacts
? Segmenting payers by and determining target contract levels
? Implementing a platform and staying on course
? Complicating factors and common pitfalls
Eric Auger has been with Putnam Associates since 1996 and a Partner since 2005. Mr. Auger has been a leader in developing and expanding Putnam’s pricing, reimbursement and managed markets practice having completed engagements across a wide range of pharma and biotech therapeutic categories, channels and national markets. In addition, Eric’s experience serving top management of major pharma and biotech clients encompasses business development and portfolio evaluation, product and business unit strategic planning, market and customer segmentation, sales force deployment and messaging strategy, and strategic decision analytics. Prior to joining Putnam, Eric worked for Bain & Company, where he served clients in banking, insurance, telecommunications, retail and manufacturing. Eric holds a BA in Economics from Providence College, an MA in International Relations from Boston University, and has completed post-graduate studies at the MIT/Sloan School of Management. Eric also lived and worked in Japan for two years prior to attending graduate school.
Putnam Associates (www.putassoc.com) is a strategy consulting firm headquartered in Boston, founded in 1988, advising the pharmaceutical, biotechnology, diagnostics, and medical device industries on a global basis. Two decades of experience and focus in their industries enable them to create significant value for their clients. Creative and disciplined strategy development processes blend with deep market knowledge for one purpose: to help their clients succeed. The company’s partnership includes: Kevin J. Gorman, Managing Partner (BA, Boston College; MBA, Harvard Business School); Richard J. Tinsley, Partner (BA, Wharton School, University of Pennsylvania; MA, Stanford University; MBA, Stanford University); John A. Gordon, Partner (BA, summa cum laude, Tufts University; MBA, Harvard Business School); Eric C. Auger, Partner (BA, Providence College; MA, Boston University); and Domenick Bertelli, Partner (AB, Harvard University; MBA, MIT Sloan School of Management).
